Xilio Therapeutics
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. The net income raised on -$76,404,000 over the previous period. Total operating expenses were $79,133,000.
Profit Margin
| 2019 | 0 | -17.31M | |
|---|---|---|---|
| 2020 | 0 | -55.21M | |
| 2021 | 0 | -74.30M | |
| 2022 | 0 | -87.29M | |
| 2023 | 0 | -76.40M |
XLO Income Statement (2019 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
Revenue | |||||
Revenue | 0 | 0 | 0 | 0 | 0 |
Cost of revenue | 1.9M | 1.84M | 1.49M | 1.06M | 240K |
Gross profit | -1.9M | -1.84M | -1.49M | -1.06M | -240K |
Operating exp. | |||||
Research and development | 52.13M | 59.20M | 51.18M | 43.91M | 14.25M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 79.13M | 89.14M | 75.04M | 54.56M | 19.02M |
Operating income | -79.13M | -89.14M | -75.04M | -54.56M | -19.02M |
Other income (expenses), net | 2.72M | 927K | -756K | -656K | 1.71M |
Income before tax | -76.40M | -88.22M | -75.8M | -55.21M | -17.31M |
Income tax expense | 0 | -927K | -1.49M | 858.70K | 0 |
Net income | -76.40M | -87.29M | -74.30M | -55.21M | -17.31M |
Earnings per share | |||||
Basic EPS | -2.78 | -3.19 | -2.72 | -2.01 | -0.63 |
Diluted EPS | -2.78 | -3.19 | -2.72 | -2.01 | -0.63 |
| Data source | Data source | Data source |